prevalent, affecting ≈20% of adults in the aging Western population. 3 A significant amount of evidence clearly shows a strong relation between metabolic syndrome and onset and progression of cardiovascular disease. 4, 5 In regard to renal disease, a clear association between metabolic syndrome and renal dysfunction has also been described. 4, 6 Thus, metabolic risk factors seem to be the driving force behind cardiovascular and CKD disease, and hence CRS. Similarly, the association between all individual components of metabolic syndrome and CRS development is now well established and is increasingly recognized as a separate disease-entity termed cardiorenal metabolic syndrome (CRMS). 1, 6, 7 At present, rodent CRS models typically involve renal ablation and coronary ligation, either alone or in combination to directly induce diastolic and systolic dysfunction. 8 An in vivo model that uses metabolic triggers may be more relevant for studies that focus on onset and early progression of CRS. Here we propose the obese diabetic Zucker fatty/ Spontaneously hypertensive heart failure F1 hybrid (ZSF1) rat strain as a model for CRMS. 9 Recently, we have reported that obese ZSF1 (ZSF1 Ob) rats develop heart failure with preserved ejection fraction (HFpEF) between weeks 10 and 20 of natural aging. 9 The ZSF1 strain also autonomously develops renal disease, making it suitable for studying CKD in relation to metabolic triggers. 10, 11 HFpEF development in ZSF1 Ob rats was characterized by progressive left ventricle (LV) diastolic dysfunction, concentric LV remodelling, and hypertrophy. 12 This was preceded by insulin resistance, glycosuria, and proteinuria. 9 This phenotype is consistent with CRMS in humans, which is defined by the presence of metabolic syndrome in addition to insulin resistance, microalbuminurina, and reduced renal function. 13 Therefore, these data indicate that the obese ZSF1 strain may be used as an in vivo model of CRS early progression against a well-defined background of metabolic injury, thus providing a model to study CRMS. ZSF1 Ob rats also experienced increased vascular stiffness and lack of NO response, consistent with endothelial dysfunction. 14 Persistent nitrosative/oxidative stress and inflammation have been observed in the coronary microvascular bed of patients with HFpEF. 15, 16 Vascular oxidative stress leading to endothelial dysfunction and inflammation has been proposed as one of the key pathways in HFpEF 17 and CRS, [18] [19] [20] and it is strongly linked to metabolic risk factors. 19, 21 However, details of the cardiac and renal microvasculature response in CRMS remain to be investigated. Consequently, we studied the microvascular changes in the heart and kidney during progression of HFpEF and renal dysfunction in ZSF1 Ob rats.
Methods

Ethics
All animal studies were carried out in accordance with the Council of Europe Convention (Directive [2010/63/EU]) for the protection of vertebrate animals used for experimental and other scientific purposes with the approval of the National and Local Animal Care Committee of Faculty of Medicine of Porto. Animal experiments were performed according to ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.
Animal Model
Nine-week-old male Wistar Kyoto (WKY, n=12), ZSF1 Lean (ZSF1 Ln, n=10), and ZSF1 Obese rats (ZSF1 Ob, n=12) were obtained from Charles River (Barcelona, Spain) and housed in a light, temperature, and humidity controlled environment after a 12-hour light-dark cycle with free access to water and standard diet (Purina diet no. 5008). Phenotypic evaluation was conducted after 1 week of acclimatization, consisting of metabolic and echocardiography studies. Weight gain was monitored every third day. In weeks 18 and 24, phenotypic evaluation was repeated. Cardiac hemodynamic measurements followed by euthanasia were performed at 20th and 25th week. Heart and kidneys were excised, weighed, fixed in formaldehyde, and embedded in paraffin for further analysis.
Echocardiography Evaluation
Rats were anesthetized by inhalation of sevoflurane (8 and 2.5%-3% for induction and maintenance, respectively; Penlon Sigma Delta), mechanically ventilated while homeostasis was maintained by anesthetic monitoring. After applying echocardiography gel a linear 15-MHz probe (Sequoia 15L8W) was positioned on the thorax. Systolic and diastolic wall thickness and cavity dimensions were recorded in M-mode and 2-dimensional (2D) echocardiography, at the level just above the papillary muscles in the parasternal short-axis view. The long-axis diastolic dimensions of the LV and transverse aortic root diameter were recorded by 2D and M-mode echocardiography, respectively, in the parasternal long-axis view. Aortic flow velocity was recorded by pulsed-wave Doppler above the aortic valve. Mitral flow velocity tracings were obtained with pulsed-wave Doppler above the mitral leaflets, peak systolic tissue velocity, and E′ were measured with tissue Doppler at the medial mitral annulus and lateral mitral annulus, respectively, and left atrial dimensions were measured at their maximum, by 2D echocardiography in the 4-chamber view. Acquisitions were conducted while suspending mechanical ventilation and recordings were averaged from 3 consecutive heartbeats (Siemens Acuson Sequoia C512). LV mass and volumes were calculated by the 2D area-length method and M-mode. For evaluation of diastolic function, peak velocity of early (E), and late (A) mitral inflow and the ratio of E over E′ were measured as an indicator of LV filling pressure. Myocardial performance index was retrieved from the mitral flow pattern. Volumes and masses were indexed for body surface area as defined by 9.1×body weight (BW) 2/3 .
Statistics
Groups were compared by 2-way ANOVA for repeated measurements, followed by Student-Newman-Keuls post hoc test using SigmaPlot 12.3 (Systat Software Inc, San Jose, CA). Data are presented as mean±SD. P<0.05 was considered significant. Alternatively, 1-way ANOVA Kruskal-Wallis test was used, followed by Dunn multiple comparison test. Detailed description of the methods is available in the Data Supplement.
Results
HFpEF Progression in ZSF1 Ob Animals
ZSF1 Ob rats had LV hypertrophy, as shown by increased echocardiographic indices of LV mass and LV posterior wall thickness at end diastole versus WKY and ZSF1 Ln at 25 weeks, and increase in LV+interventricular septum weight/ tibial length versus WKY and ZSF1 Ln at 20 and 25 weeks (Tables 1 and 2) . Echocardiographic data showed preserved systolic function in all groups as assessed by ejection fraction, fractional shortening, and cardiac index at 20 or 25 weeks ( Table 2 ). In contrast, ZSF1 Ob presented increased ratio of E to early diastolic TD mitral annulus velocity (E′), significant increase in E/E′/end-diastolic volume ratio, and increase of left atrial area ( 
ZSF1 Ob Animals Develop Multiple Subendocardial Microstructures of High Cell Density That Are Enriched in Lectin+ ECs
Hematoxylin/eosin examination of heart cross-sections revealed no major differences in tissue morphology between WKY and ZSF1 Ln at 20 or 25 weeks. However, multiple areas with high cell density were observed at subendocardial locations of ZSF1 Ob rats at both time points, which were absent in WKY and ZSF1 Ln ( Figure IAI and IAII versus IBI and IBII in the Data Supplement). High magnification assessment identified these ZSF1 Ob-specific areas as irregular star-shaped foci composed of >50 mononuclear cells, located in the interstitial space between the cardiomyocytes (Figure 1C-1G). Erythrocytes were detected in the extravascular space ( Figure 1D and 1F), or in the lumen of capillary-like arrangements ( Figure 1D and 1H), suggesting that these foci may contain vascular cells. Lectin+ ECs were organized in a well-structured microcapillary network in both WKY and ZSF1 Ln at 20 and 25 weeks (Figure 2A and 2B) . Similarly, a well-organized microcapillary network was observed in ZSF1 Ob at both 20 and 25 weeks in the areas outside the foci (Figure 2A and 2B). Quantification of lectin staining showed a significant increase in capillary area in ZSF1 Ob at 20 weeks of age compared with WKY and ZSF1 Two-way ANOVA with Student-Newman-Keuls post hoc test. n=2 to 4 animals per group at 20 weeks; n=5 to 6 animals per group at 25 weeks. Values are mean±SD. CI indicates cardiac index; dLVPW, left ventricular posterior wall measured in diastole; E/A, ratio between peak E and A waves of pulsed-wave Doppler mitral flow velocity; EDVI, end-diastolic volume indexed for body surface area; E/E′, ratio between peak E-wave velocity of pulsed-wave Doppler mitral flow and peak E′-wave velocity of tissue Doppler at the lateral mitral annulus; EF, ejection fraction; EVD; end-diastolic volume; FS, fractional shortening; HR, heart rate; LAA, left atrial area; MPI, myocardial performance or Tei index; S, peak systolic tissue Doppler velocity at the mitral annulus; and WKY, Wistar Kyoto. *P<0.05 vs week 20; †P<0.05 vs WKY 20 or 25; ‡P<0.05 vs WKY and ZSF1 Ln 20 or 25.
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Ln (9.3±1.0 versus 4.7±1.1 and 5.8±1.0, respectively; P<0.01), whereas at 25 weeks, capillary areas normalized between groups, mainly because of the increase in WKY and ZSF1 Ln ( Figure 2C ). The subendocardial foci in ZSF1 Ob also stained positive for lectin, indicating that most of the accumulated cells were endothelial cells ( Figure 2D and 2E). In contrast to the coherent lectin+ capillary structures that were found outside the foci, the bulk of lectin+ ECs inside these foci showed a distinct lack of vascular morphology with only limited luminal and monolayer organization ( Figure 2D and 2E, inserts).
ZSF1 Ob-Specific Subendocardial Foci Are Enriched in NG2+ and PDGFRβ+ Pericytes That Form Disorganized Vascular Clusters With Lectin+ and JG12+ ECs
Pericytes are vascular mural cells that are typically found in the capillary bed. They are vital for microvascular survival and regulation of blood flow. 22 Immunostaining for NG2 identified vascular pericytes located in the subendocardial foci, further validating their vascular identity. In the WKY and ZSF1 Ln, NG2+ pericytes were detected at their characteristic peri-EC localization, as shown by lectin double staining (representative cross-section of WKY at 25 weeks is shown in Figure 3A ). In contrast, in ZSF1 Ob, the number of NG2+ pericytes was markedly increased in the regions outside the foci ( Figure 3A ). In the subcardiac foci, NG2+ pericytes were also observed in close distance to lectin+ ECs ( Figure 3A and 3B). Although some coverage of vascular structures could be recognized, the majority of the NG2+ pericytes form atypical multilayered clusters mixed with lectin+ ECs ( Figure 3B ). To further validate the vascular content of the ZSF1 Ob foci, pericytes were stained with a second vascular mural cell marker PDGFRβ in combination with a second EC marker, JG12. Immunostaining experiments using cultured human vascular cells demonstrate that NG2 and PDGFRβ are suitable markers for mural cells, in particular pericytes, being minimally expressed by endothelial cells ( Figure IA in the Data Supplement). PDGFRβ+ pericytes were detected in WKY and ZSF1 Ln at peri-EC localization ( Figure 3C ). In the ZSF1 Ob, PDGFRβ+ pericytes accumulated in the foci and were atypically organized with limited perivascular coverage ( Figure 3C and 3D). In the capillary network directly surrounding these foci, an increase in PDGFRβ+ pericytes was observed when compared with the capillary network in WKY and ZSF1 Ln ( Figure 3E and 3F). The number of vascular foci increased by 9-and 20-fold in ZSF1 Ob versus WKY and by 4-and 27-fold in ZSF1 Ob versus ZSF1 Ln at 20 and 25 weeks, respectively, when quantified using the NG2+ signal (P<0.001; Figure 3G , left graph). Similarly, quantification of foci using the PDGFRβ+ signal showed increases of 7-and 25-fold in ZSF1 Ob versus WKY and of 4-and 29-fold in ZSF1 Ob versus ZSF1 Ln at 20 and 25 weeks, respectively (P<0.001; Figure 3G , right graph). The number of foci also increased in ZSF1 Ob over time based on both NG2 and PDGFRβ methods of quantification (P<0.001; Figure 3G ). Combined, these data identify the subendocardial structures as vascular cells enriched foci that specifically develop in ZSF1 Ob rats.
Increased Endothelial Cell Proliferative Activity, Fibrosis, and AGTR1 Expression in the Vascular Foci of ZSF1 Ob Animals
The large number of vascular cells in the foci point toward increased endothelial cell proliferation. We used a combination of lectin and Ki67 staining to assess the number of proliferating endothelial cells. In ZSF1 Ob foci, lectin+ ECs were enriched in nuclear Ki67 signals when compared with the surrounding tissue that displayed a regular organization of microvascular network ( Figure 4A and 4C). These results were verified using a second JG12/Ki67 staining combination, which demonstrated a similar preferential signal of Ki67 in JG12+ ECs located in the foci ( Figure 4B and 4D).
Fibrogenic activity in these pericyte-enriched foci was investigated by histological Periodic acid-Schiff examination, a staining method that is often used to detect extracellular deposition of (vascular) basal membrane glycoproteins. Extracellular fibril-like Periodic acid-Schiff+ structures were Figure 5A -5F). Double staining for lectin+ ECs and fibronectin showed limited deposition of these early fibrosis-associated extra cellular matrix components in the regular capillary network of WKY and ZSF1 Ln ( Figure 5G ). In contrast, fibronectin deposition was increased in the subendocardial foci of ZSF1 Ob, and in the vascular network surrounding the foci ( Figure 5G and 5H). Double staining for PDGFRβ+ pericytes and collagen IV, a vascular basal membrane component predominantly produced by vascular cells, showed robust collagen IV deposition in the regular capillary network of WKY and ZSF1 Ln ( Figure 5I) . Similarly, collagen IV was detected in the PDGFRβ+ foci and direct surrounding capillaries of ZSF1 Ob rats ( Figure 5I and 5J). Activation of the renin-angiotensin-aldosterone system (RAAS) may contribute to CRMS and HFpEF development in the ZSF1 Ob animals. Immunostaining for AGTR1, the angiotensin II receptor most associated with cardiac hypertrophy, VSMC hyperproliferation, and vascular constriction, showed increased expression of AGTR1 by cardiomyocytes and interstitial perivascular cells in ZSF1 Ob versus WKY and ZSF1 Ln controls in areas outside the vascular foci ( Figure 5K and 5L ). AGTR1 was highly expressed by both by lectin+ ECs and perivascular cells in the ZSF1 Ob-specific vascular foci ( Figure 5M ).
Vascular Foci of ZSF1 Ob Animals Are Preferred Recruitment Sites for Circulatory Immune Cells
To assess whether inflammatory cells contribute to the fibrogenic process, double staining for lectin+ ECs and CD3+ T cells was conducted. Perivascular CD3+ T cells were absent in the microvascular bed of WKY and ZSF1 Ln ( Figure 6A ). In contrast, perivascular CD3+ T cells were detected in limited numbers in ZSF1 Ob in the vascular foci, whereas the remaining capillary network showed no CD3+ T-cell recruitment. Similarly, double staining for lectin+ ECs and ED1+ macrophages showed an absence of perivascular macrophages in WKY and ZSF1 Ln capillary networks, whereas in ZSF1 Ob, ED1+ macrophages accumulated in the subendocardial foci, indicating active recruitment of circulating immune cells at these sites ( Figure 6B ).
Renal Function Declines in ZSF1 Ob Rats
Compared with WKY, plasma urea was not affected in ZSF1 Ln and Ob at 20 and 25 weeks. At 20 and 25 weeks, a 9-and 38-fold increase in protein/creatinine ratio was observed, respectively, in ZSF1 Ob compared with WKY (P<0.001; Table 3 ). Similarly, at 20 and 25 weeks, a 6-and 37-fold increase in protein/creatinine ratio was observed in ZSF1 Ob compared with ZSF1 Ln (P<0.001; Table 3 ). Oxidative stress, measured by thiobarbituric acid reactive substance, 
ZSF1 Ob Rats Show Degradation of Renal Endothelium and Develop Progressive Glomerulosclerosis
The highest chronic tubulointerstitial damage and glomerulosclerosis scores were measured in ZSF1 Ob compared with WKY and ZSF1 Ln at 20 and 25 weeks ( Figure 7A and 7B) . Compared with WKY, glomerulosclerosis was increased in ZSF1 Ln (11±5 versus 23±5 and 13±5 versus 24±5, P<0.05).
With age glomerulosclerosis increased in ZSF1 Ob (39±10 versus 53±14, P<0.01). Peritubular and glomerular endothelium were visualized on JG12-stained slides ( Figure 8A ). Compared with WKY and ZSF1 Ln, the percentage of peritubular and glomerular endothelium decreased in ZSF1 Ob (Figure 8B and 8C ).
Discussion
The main findings of this study are (1) the obese ZSF1 rat strain is a suitable in vivo model for CRMS, sharing characteristics with the human syndrome during the earliest onset of 
ZSF1 Ob Rats as a Suitable Model for CRMS-Metabolic Syndrome as a Trigger for Chronic CRS
Humans with metabolic derangements such as obesity, hypertension, hyperglycemia, and dyslipidemia-all recognized as important risk factors for CKD and cardiovascular disease 23,24often present with preclinical diastolic dysfunction, 25 diastolic heart failure, or HFpEF. 26, 27 In current and previous reports, we could validate that the ZSF1 Ob animals share these characteristics with patients with metabolic syndrome 2 : ZSF1 Ob rats are obese (65% and 45% increase compared with WKY and ZSF1 Ln, respectively, Table 1 ), hypertensive (46% and 19% increase in mean blood pressure compared with WKY and ZSF1 Ln, Table II in the Data Supplement), and show elevated fasting plasma glucose levels (65% and 45% increase compared with WKY and ZSF1 Ln, respectively 9 ), whereas other studies have reported hypertriglyceridemia (increase of 
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>25-fold) and hypercholesterolemia (increase of >5-fold) in ZSF1 Ob versus ZSF1 Ln. 10, 28 Furthermore, CRMS in humans is defined by the presence of metabolic syndrome in addition to insulin resistance, microalbuminurina, and reduced renal function. 13 Current and previous findings demonstrate that ZSF1 Ob develops proteinuria from 10 weeks onwards, 9 whereas early signs of HFpEF were detected from 14 weeks onwards. Similarly at 10 weeks, increased oral glucose tolerance and insulin resistance, glycosuria and significant weight gain can be detected. 9 These observations indicate that the presentation of metabolic risk factors accompanies the onset of renal dysfunction (signified by proteinuria) and precedes HFpEF development in ZSF1 Ob rats, which is consistent with a pathophysiological course of CRMS in ZSF1 Ob in which metabolic and renal complications induce cardiac dysfunction. 18 On the basis of these combined data, we therefore propose ZSF1 Ob as a small animal model for metabolic syndrome-induced CRS (and thus CRMS), in which the combined metabolic risk factors act together to trigger early onset and progression of CKD and HF, creating the downward spiral of disease progression that is so typical for patients with chronic CRS. 10
Microvascular Fibrotic Changes in ZSF1 Ob Rats
CRMS was first suggested as a disease entity in 2004. 29 Already in this first publication, a relation with endothelial dysfunction was proposed. 29 Endothelial injury is implicated in CRS, 20 whereas in HFpEF patients, vascular changes represented by endothelial dysfunction have been reported. 30 A direct link between heart failure, vascular activation, metabolic comorbidities, and CKD was presented by Shestakova et al, 19 who demonstrated a correlation between endothelial dysfunction and the hallmarks of HF in CRS patients with type 1 diabetes mellitus. In line with these studies, our data show changes in the coronary microvascular bed of ZSF1 Ob rats: endothelial and mural cells form atypical vascular patches of cells, with remarkable increases in proliferation rate. Not only do these structures lack functional organization they also seem to act as origin sites of fibrosis, for we could demonstrate enriched deposition of fibrosis-associated extra cellular matrix components such as fibronectin and collagen type IV in these vascular foci.
In CRS rat models that use subtotal nephrectomy in combination with coronary ligation to initiate ischemic heart disease, a decrease in LV microvascular density was reported to be associated with systolic dysfunction. 31, 32 Other clinical and experimental studies provide evidence that coronary microvascular rarefaction in diastolic and hypertrophic heart failure promotes tissue hypoxia, cell death, and fibrosis, all contributing to the progression from compensated hypertrophy to contractile dysfunction. 33, 34 In adults, vascular proliferation is part of the compensatory and repair response to local hypoxia and tissue damage in which endothelial cells proliferate and migrate into the ischemic injury site during macrophage influx and phagocytosis of necrotic tissue. As repair proceeds, dead Extensive myocardial fibrosis is one of the hallmarks of CRMS. Previously, we reported that at 20 weeks, cardiac hypertrophy was increased in ZSF1 Ob versus ZSF1 Ln and WKY, but overall levels of myocardial fibrosis remained comparable between groups. 9 In contrast, glomerulosclerosis score in the kidneys ( Figure 8B ) was significantly increased in ZSF1 Ob versus the other 2 groups. Thus, the effect of metabolic risk factors on kidney fibrosis seems to precede the effects on fibrosis in the myocardium in the ZSF1 Ob animals. In this study, we could demonstrate that onset of fibrosis is present in the subendocardial vascular foci at 20 and 25 weeks in ZSF1 Ob rats. This was accompanied by vascular inflammation, yet another hallmark of CRMS.
On the basis of our observations to date, we hypothesize that the hyperproliferative vascular reaction in ZSF1 Ob heart is part of a destructive response that leads to replacement of functional vascular structures by fibrotic tissue with semi and nonfunctional microvascular clusters, which may ultimately deteriorate into large fibrotic areas that are completely devoid of vascular support, in line with the previously reported vascular rarefaction phenotype. Additional studies are planned to further elucidate this highly dynamic process and to validate if microvascular hyperproliferation of pre-existing vessels indeed precedes fibrogenesis and vascular rarefaction in CRMS.
Potential Impact of Current Findings on the Field of CRMS Research
Chronic CRS type 2, which is initiated by chronic cardiac dysfunction (such as congestive HF), and type 4, initiated by chronic renal dysfunction (resulting in LV hypertrophy and diastolic HF), are currently under-recognized syndromes in the cardiovascular research community in comparison with acute CRS types. This is largely because of the lack of a suitable animal model to mimic the human condition. However, the population of patients with chronic types of CRS is substantial: in adult patients with congestive HF, it has been reported that 31% of NYHA III and 39% of NYHA IV patients had renal dysfunction. 37 Recent findings presented in the PREVEND study also showed that early onset of renal dysfunction, indicated by albuminuria, is a strong predictor for new onset of HFpEF, but not HFrEF. 38 Others have also demonstrated that the prevalence of LV hypertrophy is significantly increased in patients with CKD from mild renal impairment onwards. 39 These findings are consistent with the concept that the synergy between renal and cardiac dysfunction is a driving factor in the early disease onset of HFpEF. An improved understanding of the disease mechanism of, in The ZSF1 Ob strain presents a suitable model to investigate the contribution of different disease pathways to CRMS, as the disease course resembles the onset phase of chronic CRS within the first 10 to 25 weeks of the animals' lifespan.
In particular, studies that investigate the relationship between metabolic risk factors and endothelial dysfunction could shed further light on the contribution of vascular injury to HF in chronic CRMS.
Limitations of This Study
The ZSF1 Ob model described in this article is not suitable for studying type 1 and type 3 CRS because these forms require acute cardiac and renal failure to adequately mimic the human conditions, and may involve different disease mechanisms compared with the chronic forms (see review of disease pathogeneses of CRS subtypes). 18 A more suitable model for acute CRS would be surgical induction methods for myocardial infarction such as coronary ligation, and subtotal nephrectomy for severe renal dysfunction. Previous studies have indicated that a dual injury model to heart and kidneys is needed to produce a more robust acceleration of renal failure and heart failure with reduced ejection fraction that are typical for acute CRS. 40, 41 However, the causal relationship between metabolic risk factors and chronic CRS can be better studied in the ZSF1 Ob model, as this would best imitate the natural course of the disease in patients with chronic CRS. The addition of ZSF1 Ob to our arsenal of animal models for CRS will greatly expand our means to adequately study mechanisms in the earliest phases of disease.
In addition to the proposed mechanism of vascular fibrosis-mediated CRMS, other disease mechanisms could trigger CRS, including low-cardiac output leading to impaired renal perfusion, which vice versa leads to kidney-mediated RAAS and sympathetic activation. Initial renal dysfunction could also induce chronic CRS via RAAS and sympathetic activation, in addition to Na + and H 2 O overload, hypertension, accumulation of uremic toxins and calcium and phosphate abnormalities that all contribute to cardiovascular complications. Furthermore, renal impairment and subsequent dysregulation of erythropoietin contributes to anemia, which further aggravate hypoxia in both organs. 18 In this study, we have not specifically assessed the contribution of these mechanisms to CRS development in the ZSF1 Ob model. However, cardiac output represented by the indexed cardiac output (cardiac index, in Table 2 ) is similar between the 3 groups at both time points assessed. In addition, ZSF1 Ob animals are indeed hypertensive, and expression of AGTR1, the main receptor for RAAS-mediated effects on the cardiovascular system, was increased in LV sections of the ZSF1 Ob group, particularly at the vascular foci. Further systematic evaluation will help identify for which specific pathological mechanisms of chronic CRS, the ZSF1 Ob strain is a suitable research model.
In conclusion, this study demonstrates that the ZSF1 Ob rat strain is a suitable in vivo model for CRMS, sharing many characteristics with the human CRS during the earliest onset of the disease, as triggered and mediated by metabolic risk factors. Further studies in the classic pathways of CRMS using this ZSF1 Ob model will enhance our understanding of the contribution of microvascular and metabolic changes during the onset of CRMS. 
